FDA approval! That is where it counts. You can't cite any! Why?...

FDA approval!

That is where it counts.

You can't cite any! Why? because MSB is the world leader in the field.

Also it's absurd citing the very company that MSB has bought. Very cheeky, but worth a try.

Haven't you got work to do? Or is this your work?

Clearly I said BEST CASE SCENARIO.

But you failed to understand that, as you fail deliberately or otherwise to comprehend things like fast tracking.

You seem to pretend all experience is subjectively yours. You don't have any with an entirely new precedent of stem cells.

So the fact that the FDA is prepared to look at fast tracking stem cell technology at the half way mark, and has scheduled this, and this is on the public record is giving you comprehension problems.

You like to refer to irrelevancies, like your own experience with the FDA which has NOTHING to do with stem cells. Nothing!

Entirely possible best case scenario early 2017.

(So shoot me...lol!)